MUSTANG BIO, INC. (MBIO)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$15.6M
Stockholders' Equity
$7.5M
Cash & Equivalents
$15.2M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, MUSTANG BIO, INC. reported net income of -$1.1M and total assets of $15.6M. Every figure below is taken directly from MUSTANG BIO, INC.'s SEC filings: each links to the source document on EDGAR.

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025—-$1.9M
FY2024—-$15.8M
FY2023—-$51.6M
FY2022—-$77.5M
FY2021—-$66.4M
FY2020—-$60.0M
FY2019—-$46.4M
FY2018—-$30.7M
FY2017—-$31.3M
FY2016—-$12.7M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 15, 2026on EDGAR ↗
10-QAug 5, 2026on EDGAR ↗
10-QMay 5, 2026on EDGAR ↗
8-KApr 17, 2026on EDGAR ↗
10-KMar 19, 2026on EDGAR ↗
8-KDec 23, 2025on EDGAR ↗
DEF 14ADec 3, 2025on EDGAR ↗
10-QNov 7, 2025on EDGAR ↗
10-QAug 8, 2025on EDGAR ↗
8-KJul 9, 2025on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$15.6Msource ↗
Stockholders’ Equity$7.5Msource ↗
Cash & Equivalents$15.2Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue—source ↗
Net Income-$1.1Msource ↗
Operating Income-$1.2Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense—source ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.16source ↗
EPS (basic)$-0.16source ↗
Shares Outstanding—source ↗
Cash from Operations-$967,000source ↗
Cash from Financing-$141,000source ↗
Cash from Investing$0source ↗

Restatement history

Point-in-time

3 of 208 annual fact-keys were materially restated between filings: what MUSTANG BIO, INC. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

See the restatement detail →

Deeper fundamentals

A free API key reaches MBIO’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Get a free API key →See plans

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/MBIO

MCP tool: get_sec_fundamentals ticker=MBIO

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/MBIO/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=MBIO as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/MBIO/history

MCP tool: get_fundamentals_history ticker=MBIO

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/financial-health/MBIO

MCP tool: get_financial_health ticker=MBIO

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.